SI-BONE/$SIBN
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About SI-BONE
SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.
Ticker
$SIBN
Sector
Primary listing
Industry
Health Care Equipment & Supplies
Headquarters
Employees
349
ISIN
US8257041090
Website
SI-BONE Metrics
BasicAdvanced
$771M
-
-$0.63
0.82
-
Price and volume
Market cap
$771M
Beta
0.82
52-week high
$20.05
52-week low
$11.70
Average daily volume
488K
Financial strength
Current ratio
8.525
Quick ratio
7.144
Long term debt to equity
21.561
Total debt to equity
22.213
Interest coverage (TTM)
-9.53%
Profitability
EBITDA (TTM)
-26.117
Gross margin (TTM)
79.25%
Net profit margin (TTM)
-15.03%
Operating margin (TTM)
-17.38%
Revenue per employee (TTM)
$510,000
Management effectiveness
Return on assets (TTM)
-8.50%
Return on equity (TTM)
-15.96%
Valuation
Price to revenue (TTM)
4.284
Price to book
4.59
Price to tangible book (TTM)
4.59
Price to free cash flow (TTM)
-37.353
Free cash flow yield (TTM)
-2.68%
Free cash flow per share (TTM)
-48.43%
Growth
Revenue change (TTM)
22.60%
Earnings per share change (TTM)
-41.19%
3-year revenue growth (CAGR)
24.21%
10-year revenue growth (CAGR)
16.05%
3-year earnings per share growth (CAGR)
-29.95%
10-year earnings per share growth (CAGR)
-25.09%
What the Analysts think about SI-BONE
Analyst ratings (Buy, Hold, Sell) for SI-BONE stock.
Bulls say / Bears say
SI-BONE achieved a record worldwide revenue of approximately $49 million in Q4 2024, marking a 26% year-over-year growth, and reached adjusted EBITDA profitability for the first time, indicating strong financial health and operational efficiency. (Nasdaq)
The company expanded its U.S. active physician base by 23% to 1,390 in Q4 2024, reflecting increased adoption of its products and a growing market presence. (StockTitan)
SI-BONE's commercialization of innovative products like iFuse TORQ TNT and the granting of Transitional Pass-Through payment status for Granite in CY2025 position the company for continued growth and market leadership. (StockTitan)
Despite revenue growth, SI-BONE reported a net loss of $30.9 million in 2024, highlighting ongoing profitability challenges. (GlobeNewswire)
The company's operating expenses increased by approximately 7% to $167.4 million in 2024, which could pressure margins if revenue growth slows. (GlobeNewswire)
SI-BONE's gross margin remained flat at around 79% in Q3 2024 compared to the previous year, indicating potential challenges in improving profitability. (SPINEMarketGroup)
Data summarised monthly by Lightyear AI. Last updated on 9 Jun 2025.
SI-BONE Financial Performance
Revenues and expenses
SI-BONE Earnings Performance
Company profitability
SI-BONE News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for SI-BONE stock?
SI-BONE (SIBN) has a market cap of $771M as of June 27, 2025.
What is the P/E ratio for SI-BONE stock?
The price to earnings (P/E) ratio for SI-BONE (SIBN) stock is 0 as of June 27, 2025.
Does SI-BONE stock pay dividends?
No, SI-BONE (SIBN) stock does not pay dividends to its shareholders as of June 27, 2025.
When is the next SI-BONE dividend payment date?
SI-BONE (SIBN) stock does not pay dividends to its shareholders.
What is the beta indicator for SI-BONE?
SI-BONE (SIBN) has a beta rating of 0.82. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.